Clinical trial Recruiting at 1 site Observational Ages 21 to 99

Understanding heart muscle response to high blood pressure

Official title: Response of the Myocardium to Hypertrophic Conditions in the Adult Population

Run by National Heart Centre Singapore · NCT02670031 · Data updated 2026-11-12

This study looks at how high blood pressure affects the heart muscle in people with hypertension to see if certain heart changes can help improve treatment strategies.

Quick facts

Study typeObservational
Ages21 Years to 99 Years
SexAll
Enrollment2000 (estimated)
SponsorNational Heart Centre Singapore
Academic / other
Locations1 site (Singapore)
StatusRecruiting
StartedJanuary 2016
Main results expectedSeptember 2031
Study endsSeptember 2031
Registry record updatedAugust 2, 2023
Trial IDNCT02670031 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 21 and over with physician-diagnosed essential hypertension who are either newly diagnosed or have resistant hypertension.

Probably not a fit

Patients with known secondary hypertension or contraindications to cardiovascular magnetic resonance will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the effects of hypertension on the heart muscle, specifically focusing on left ventricular hypertrophy and myocardial fibrosis. Utilizing advanced cardiovascular magnetic resonance imaging and high-sensitivity cardiac troponin blood assays, the study aims to assess the significance of myocardial fibrosis in a large cohort of 2000 patients with hypertension. Participants will undergo follow-up assessments over at least one year to monitor changes and outcomes related to their heart health. The findings could provide insights into better management strategies for hypertensive heart disease.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of hypertensive heart disease, potentially reducing the risk of heart failure in patients.

How similar studies have gone: While this study employs advanced imaging techniques, similar studies have shown varying degrees of success in understanding hypertensive heart disease, making this approach both relevant and necessary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. 21 years and over
2. Physician diagnosed essential hypertension, on at least 1 medication for blood pressure control
3. Newly diagnosed hypertension: systolic blood pressure 140mmHg or greater (diastolic blood pressure 90mmHg or greater) on at least 2 office visits (Weber 2013) and not started on any anti hypertensive medications at time of ambulatory blood pressure monitoring
4. Resistant hypertension: persistent systolic blood pressure 140mmHg or greater (diastolic blood pressure 90mmHg or greater) despite on at least 3 anti-hypertensive medications (Jennings 2013; Weber 2013)

Exclusion Criteria:

1. Known secondary hypertension: renal causes (renal artery stenosis, chronic renal failure); endocrine causes (aldosterone excess, pheochromocytoma, cushing's syndrome, hyperthyroidism); cardiac causes (coarctation of the aorta)
2. Contraindications to cardiovascular magnetic resonance: implantable devices, cerebral aneurysm clips, cochlear implants, renal impairment (GRF \<30ml/min/1.73m2), claustrophobia and women who are pregnant or breast-feeding
3. Limited life expectancy
4. On-going unstable medical conditions: hypertensive crisis, acute coronary syndromes or acute heart failure
5. History of coronary artery disease, ischemic heart disease
6. History of transient ischemic attacks or cerebrovascular events
7. History of atrial fibrillation
8. History of heart failure

Where it's running

  • National Heart Centre Singapore
    Singapore, Singapore
    Recruiting

Study contacts

  • Principal investigator: Calvin WL Chin, MBBS, PhD — National Heart Centre Singapore
  • Study coordinator: Mu Jie Liew
  • Email: liew.mu.jie@nhcs.com.sg
  • Phone: 82002052

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.